Global Medical REIT Inc (NASDAQ:GMRE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.

According to Zacks, “Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. “

A number of other equities analysts have also recently commented on GMRE. FBR & Co reaffirmed an “outperform” rating and issued a $10.00 target price on shares of Global Medical REIT in a report on Tuesday, July 11th. TheStreet raised Global Medical REIT from a “d” rating to a “c-” rating in a report on Monday, July 10th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Global Medical REIT currently has an average rating of “Buy” and an average price target of $10.67.

Global Medical REIT (NASDAQ GMRE) opened at 9.25 on Tuesday. Global Medical REIT has a 12 month low of $6.73 and a 12 month high of $11.24. The stock has a 50 day moving average price of $9.10 and a 200 day moving average price of $9.04.

Global Medical REIT (NASDAQ:GMRE) last announced its earnings results on Thursday, August 10th. The company reported ($0.04) EPS for the quarter, missing the Zacks’ consensus estimate of $0.13 by $0.17. Global Medical REIT had a negative return on equity of 6.70% and a negative net margin of 54.55%. The company had revenue of $7.42 million during the quarter, compared to the consensus estimate of $6.16 million. Equities analysts expect that Global Medical REIT will post ($0.09) EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Global Medical REIT Inc (NASDAQ:GMRE) Lowered to “Hold” at Zacks Investment Research” was reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.watchlistnews.com/global-medical-reit-inc-nasdaqgmre-lowered-to-hold-at-zacks-investment-research/1488341.html.

In other Global Medical REIT news, Chairman Jeffrey Busch purchased 11,100 shares of the business’s stock in a transaction on Friday, June 30th. The stock was acquired at an average price of $9.00 per share, for a total transaction of $99,900.00. Following the purchase, the chairman now owns 20,110 shares of the company’s stock, valued at approximately $180,990. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

A number of large investors have recently modified their holdings of GMRE. State Street Corp raised its stake in shares of Global Medical REIT by 9.7% in the second quarter. State Street Corp now owns 234,183 shares of the company’s stock worth $2,094,000 after buying an additional 20,804 shares during the last quarter. Goldman Sachs Group Inc. acquired a new stake in shares of Global Medical REIT during the second quarter worth about $339,000. Parametric Portfolio Associates LLC raised its stake in shares of Global Medical REIT by 18.9% in the second quarter. Parametric Portfolio Associates LLC now owns 31,546 shares of the company’s stock worth $282,000 after buying an additional 5,017 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Global Medical REIT by 0.8% in the second quarter. Vanguard Group Inc. now owns 521,977 shares of the company’s stock worth $4,667,000 after buying an additional 4,044 shares during the last quarter. Finally, Northern Trust Corp raised its stake in shares of Global Medical REIT by 2.0% in the second quarter. Northern Trust Corp now owns 147,978 shares of the company’s stock worth $1,323,000 after buying an additional 2,873 shares during the last quarter.

Global Medical REIT Company Profile

Global Medical REIT Inc focuses on operating as a real estate investment trust. The Company is engaged primarily in the acquisition and leasing of licensed purpose-built healthcare facilities in certain markets with various clinical operators. The Company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals and outpatient treatment centers.

Get a free copy of the Zacks research report on Global Medical REIT (GMRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Global Medical REIT (NASDAQ:GMRE)

Receive News & Ratings for Global Medical REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.